Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03740802
Recruitment Status : Completed
First Posted : November 14, 2018
Last Update Posted : November 27, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:
Retrospective study in the surgical intensive care unit of the Brest Teaching Hospital (France) during a 6-months period (January 2015 -May 2015) to study the independent association between hypophosphatemia and 28-day infection.

Condition or disease
Hypophosphatemia Infection

Layout table for study information
Study Type : Observational
Actual Enrollment : 264 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Evaluation of Hypophosphatemia as a Predictor of Sepsis in Surgical Resuscitation Units.
Actual Study Start Date : January 26, 2018
Actual Primary Completion Date : April 9, 2018
Actual Study Completion Date : April 9, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sepsis




Primary Outcome Measures :
  1. Number of patients with sepsis within 28 days after ICU admission [ Time Frame: 28 days since the ICU admission ]
    Sepsis was defined according to the criteria of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients admitted to 15-bed surgical ICU between January 1, 2015 and June 31, 2015 were screened for inclusion.
Criteria

Inclusion Criteria:

  • Adults

Exclusion Criteria:

  • Less than 18 years old
  • Infected at admission

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03740802


Locations
Layout table for location information
France
CHRU de Brest
Brest, France, 29609
Sponsors and Collaborators
University Hospital, Brest

Layout table for additonal information
Responsible Party: University Hospital, Brest
ClinicalTrials.gov Identifier: NCT03740802     History of Changes
Other Study ID Numbers: PORPOISE2-REA (29BRC18.0022)
First Posted: November 14, 2018    Key Record Dates
Last Update Posted: November 27, 2018
Last Verified: January 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypophosphatemia
Phosphorus Metabolism Disorders
Metabolic Diseases